Blackstone funds new trials of Sanofi’s Sarclisa in myeloma
Sanofi has agreed a deal with life sciences investor Blackstone to help fund clinical trials of a new formulation of Sarclisa for blood cancer multiple […]
Sanofi has agreed a deal with life sciences investor Blackstone to help fund clinical trials of a new formulation of Sarclisa for blood cancer multiple […]
Private equity firm Blackstone has agreed to provide up to $250 million in financing to UK biotech Autolus Therapeutics, to help it take acute lymphoblastic […]
After more than doubling its patient volumes during the pandemic, Carbon Health raised funding to further its growth plans. The company said it plans to […]
The new joint venture will bring K Health’s artificial intelligence-driven technology to the consumer, employer and insurer markets. The solution enables patients to understand their […]
The San Francisco-based company aims to complete at least one Phase III study by 2025, and it is weighing an IPO next year to fund […]
Takeda has joined the ranks of big pharma companies jettisoning consumer health businesses in order to concentrate on higher-margin prescription drugs. The drugmaker is divesting […]
Shots: Takeda and Blackstone sign an agreement to divest it consumer health care business unit for $2.3B. The transaction expected to be closed by Mar […]
Ancestry, which grew from a genealogy tracking tool to offering DNA tests for a number of healthconditions, reached a deal to be acquired by Blackstone […]
Copyright © 2024 | WordPress Theme by MH Themes